Bragar Eagel & Squire, P.C. Is Investigating the Board of Directors of Liberator Medical Holdings, Inc. (LBMH) on Behalf of S...
20 Novembre 2015 - 11:30PM
Business Wire
Bragar Eagel & Squire, P.C. is investigating potential
claims on behalf of Liberator Medical Holdings, Inc. (NYSE:
LBMH) investors concerning the proposed acquisition of the company
by C. R. Bard, Inc. for approximately $181 million.
The investigation concerns whether the company’s board of
directors violated their fiduciary duties by failing to maximize
stockholder value. Under the terms of the proposed transaction,
Liberator Medical’s stockholders will receive $3.35 in cash for
each Liberator Medical share they own.
However, at least one analyst set a target price of $8.00 per
Liberator Medical share.
If you purchased Liberator Medical securities, have information
or would like to learn more about these claims, or have any
questions concerning this announcement or your rights or interests
with respect to these matters please contact J. Brandon Walker,
Esq. by email at investigations@bespc.com, or telephone at (212)
355-4648, or by filling out this contact form. There is no cost or
obligation to you.
Bragar Eagel & Squire, P.C. is a New York-based law firm
concentrating in commercial and securities litigation. For
additional information, please go to www.bespc.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151120005918/en/
Bragar Eagel & Squire, P.C.J. Brandon Walker, Esq.,
212-355-4648investigations@bespc.com
Liberator Medical Holdings, Inc. (AMEX:LBMH)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Liberator Medical Holdings, Inc. (AMEX:LBMH)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about (American Stock Exchange): 0 recent articles
Plus d'articles sur Liberator Medical Holdings, Inc.